Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI reads chest X-Rays to spot deadly ICU lung infections

NCT ID NCT07509697

Diagnosis Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether an artificial intelligence (AI) tool can help doctors diagnose ventilator-associated pneumonia (a serious lung infection) in ICU patients. Researchers analyzed chest X-rays from 119 adults on breathing machines, comparing the AI's readings to doctors' assessments. The goal was to see if AI could make X-ray interpretation more consistent and reliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

119 people

The number who actually took part.

Started

Mar 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients admitted to a tertiary care anesthesia intensive care unit who required invasive mechanical ventilation and received a clinical diagnosis of ventilator-associated pneumonia (VAP). Patients were identified retrospectively through hospital electronic medical records and infection control committee databases. This cohort represents a critically ill ICU population with high disease severity and diverse comorbid conditions.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) * Admission to the anesthesia intensive care unit * Requirement of invasive mechanical ventilation for at least 48 hours * Clinical diagnosis of ventilator-associated pneumonia (VAP) based on institutional criteria * Availability of at least one chest X-ray prior to VAP diagnosis and one chest X-ray at the time of diagnosis * Availability of digital chest radiographs in the PACS system suitable for analysis Exclusion Criteria: * Age \<18 years * Absence of accessible digital chest radiographs * Chest radiographs with severe technical limitations preventing evaluation * Chest radiographs that could not be processed by the AI system (no score generated) * Presence of extensive pre-existing infiltrative lung disease preventing reliable assessment of new infiltrates * Missing key clinical data (e.g., VAP diagnosis date, mechanical ventilation duration)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence (AI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bacterial pneumonia Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Artificial intelligence (AI) Intensive care unit (ICU) Pneumonia - bacterial Radiography, thoracic Ventilator associated pneumonia

Contacts and locations

Locations

  • Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital

    Yenimahalle, Ankara, 06370, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.